Copy to clipboard 
Neo Medical commenced U.S. commercial launch of the Neo Instant MIS Access platform for posterior thoracic, lumbar, and sacral minimally invasive surgery (MIS) procedures, designed to address many of the operational barriers that continue to limit MIS’s wider adoption.
The system is commercially available in the United States, with launches in Europe and other international markets expected to follow.
The launch addresses one of the persistent barriers to broader MIS adoption: the operational infrastructure required to deliver minimally invasive procedures consistently across surgical settings. It supports Neo’s vision of a fully integrated, sterile-ready procedural ecosystem spanning access, instrumentation, advanced materials, force-control technologies, and intraoperative data.
Internal value models indicate that the Neo Instant MIS Access platform requires no capital investment, can be prepared in less than 2 minutes, and may reduce per-case operational burden by up to $2,500 compared with conventional MIS access infrastructure. In turnover-constrained facilities, the system may also support increases in operating room throughput and procedural capacity.
The launch extends Neo Medical’s strategy of reducing procedural complexity in spine surgery through sterile-ready technologies, modular instrumentation, advanced materials, proprietary Force Control Technology, and intraoperative augmented reality capabilities.
“The future of minimally invasive spine surgery is no longer defined by surgical technique alone,” said Vincent Lefauconnier, Co-Founder and CEO of Neo Medical. “It is defined by how efficiently healthcare systems can deliver those procedures at scale. We believe the next frontier in MIS adoption is operational simplicity, and Instant MIS Access was designed specifically to address that challenge.”
Source: Neo Medical
Neo Medical commenced U.S. commercial launch of the Neo Instant MIS Access platform for posterior thoracic, lumbar, and sacral minimally invasive surgery (MIS) procedures, designed to address many of the operational barriers that continue to limit MIS’s wider adoption.
The system is commercially available in the United States, with launches in...
Neo Medical commenced U.S. commercial launch of the Neo Instant MIS Access platform for posterior thoracic, lumbar, and sacral minimally invasive surgery (MIS) procedures, designed to address many of the operational barriers that continue to limit MIS’s wider adoption.
The system is commercially available in the United States, with launches in Europe and other international markets expected to follow.
The launch addresses one of the persistent barriers to broader MIS adoption: the operational infrastructure required to deliver minimally invasive procedures consistently across surgical settings. It supports Neo’s vision of a fully integrated, sterile-ready procedural ecosystem spanning access, instrumentation, advanced materials, force-control technologies, and intraoperative data.
Internal value models indicate that the Neo Instant MIS Access platform requires no capital investment, can be prepared in less than 2 minutes, and may reduce per-case operational burden by up to $2,500 compared with conventional MIS access infrastructure. In turnover-constrained facilities, the system may also support increases in operating room throughput and procedural capacity.
The launch extends Neo Medical’s strategy of reducing procedural complexity in spine surgery through sterile-ready technologies, modular instrumentation, advanced materials, proprietary Force Control Technology, and intraoperative augmented reality capabilities.
“The future of minimally invasive spine surgery is no longer defined by surgical technique alone,” said Vincent Lefauconnier, Co-Founder and CEO of Neo Medical. “It is defined by how efficiently healthcare systems can deliver those procedures at scale. We believe the next frontier in MIS adoption is operational simplicity, and Instant MIS Access was designed specifically to address that challenge.”
Source: Neo Medical
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
